Related Experiment Video
Updated: Jun 22, 2026
07:13
Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
Published on: June 28, 2024
Sensitive and multiplexed detection of proteomic antigens via quantum dot aggregation
1Interdisciplinary Program in Materials Science, Vanderbilt University, Nashville, Tennessee 37235, USA.
Nanomedicine : Nanotechnology, Biology, and Medicine
|June 16, 2009
Summary
A novel quantum dot (QD) assay enables rapid, single-step quantification of multiple proteomic biomarkers. This method uses self-assembling QD-antibody conjugates for sensitive disease detection and monitoring.
Area of Science:
- Biotechnology
- Nanotechnology
- Proteomics
Background:
- Current proteomic biomarker quantification methods can be time-consuming and complex.
- There is a need for rapid, sensitive, and multiplexed assays for early disease detection and treatment monitoring.
Purpose of the Study:
- To develop a rapid, single-step, solution-phase method for quantifying multiple proteomic biomarkers.
- To demonstrate the utility of quantum dot (QD) self-assembly for sensitive and multiplexed biomarker detection.
Main Methods:
- Utilized nanoscale quantum dot-antibody conjugates that self-assemble into microscale aggregates upon binding to specific antigens.
- Employed flow cytometry to discriminate and quantify QD aggregates.
- Used two distinct QD populations for simultaneous detection of two biomarkers (multiplexed detection).
Main Results:
- Successfully demonstrated multiplexed detection of vascular endothelial growth factor A and angiopoietin-2 at picomolar concentrations.
- Achieved femtomolar sensitivity limits in nonmultiplexed detection.
- Quantified QD aggregates, correlating their signal to antigen concentration.
Conclusions:
- The developed QD-based assay offers a rapid and sensitive approach for proteomic biomarker quantification.
- This technique holds potential for low-cost early disease detection, screening, and monitoring therapeutic response.
